162 related articles for article (PubMed ID: 19539919)
1. Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.
Gupta AK; Pinsky P; Rall C; Mutch M; Dry S; Seligson D; Schoen RE
Gastrointest Endosc; 2009 Aug; 70(2):322-30. PubMed ID: 19539919
[TBL] [Abstract][Full Text] [Related]
2. Aberrant crypt foci: what we know and what we need to know.
Gupta AK; Pretlow TP; Schoen RE
Clin Gastroenterol Hepatol; 2007 May; 5(5):526-33. PubMed ID: 17433788
[TBL] [Abstract][Full Text] [Related]
3. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
Gupta AK; Schoen RE
Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
[TBL] [Abstract][Full Text] [Related]
4. Endocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum: a prospective in vivo study.
Cipolletta L; Bianco MA; Rotondano G; Piscopo R; Meucci C; Prisco A; Cipolletta F; de Gregorio A; Salvati A
Endoscopy; 2009 Feb; 41(2):129-32. PubMed ID: 19214891
[TBL] [Abstract][Full Text] [Related]
5. Role of aberrant crypt foci detected using high-magnification-chromoscopic colonoscopy in human colorectal carcinogenesis.
Hurlstone DP; Cross SS
J Gastroenterol Hepatol; 2005 Feb; 20(2):173-81. PubMed ID: 15683417
[TBL] [Abstract][Full Text] [Related]
6. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
[TBL] [Abstract][Full Text] [Related]
7. Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine.
Kowalczyk M; Orłowski M; Klepacki Ł; Zinkiewicz K; Kurpiewski W; Kaczerska D; Pesta W; Zieliński E; Siermontowski P
BMC Cancer; 2020 Feb; 20(1):133. PubMed ID: 32075595
[TBL] [Abstract][Full Text] [Related]
8. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
[TBL] [Abstract][Full Text] [Related]
9. Classification of aberrant crypt foci and microadenomas in human colon.
Roncucci L; Medline A; Bruce WR
Cancer Epidemiol Biomarkers Prev; 1991; 1(1):57-60. PubMed ID: 1845171
[TBL] [Abstract][Full Text] [Related]
10. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of prevalence and risk factors for aberrant crypt foci.
Mutch MG; Schoen RE; Fleshman JW; Rall CJ; Dry S; Seligson D; Charabaty A; Chia D; Umar A; Viner J; Hawk E; Pinsky PF
Clin Gastroenterol Hepatol; 2009 May; 7(5):568-74. PubMed ID: 19418605
[TBL] [Abstract][Full Text] [Related]
12. Histology of aberrant crypt foci in the human colon.
Di Gregorio C; Losi L; Fante R; Modica S; Ghidoni M; Pedroni M; Tamassia MG; Gafà L; Ponz de Leon M; Roncucci L
Histopathology; 1997 Apr; 30(4):328-34. PubMed ID: 9147080
[TBL] [Abstract][Full Text] [Related]
13. BASIC (BLI Adenoma Serrated International Classification) classification for colorectal polyp characterization with blue light imaging.
Bisschops R; Hassan C; Bhandari P; Coron E; Neumann H; Pech O; Correale L; Repici A
Endoscopy; 2018 Mar; 50(3):211-220. PubMed ID: 29065437
[TBL] [Abstract][Full Text] [Related]
14. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
15. Gene expression patterns distinguish colonoscopically isolated human aberrant crypt foci from normal colonic mucosa.
Glebov OK; Rodriguez LM; Soballe P; DeNobile J; Cliatt J; Nakahara K; Kirsch IR
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2253-62. PubMed ID: 17119054
[TBL] [Abstract][Full Text] [Related]
16. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
17. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.
Figueiredo P; Donato M; Urbano M; Goulão H; Gouveia H; Sofia C; Leitão M; Freitas D
Int J Colorectal Dis; 2009 Apr; 24(4):441-50. PubMed ID: 18769883
[TBL] [Abstract][Full Text] [Related]
18. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
19. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
[TBL] [Abstract][Full Text] [Related]
20. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
